4
Changes in Ownership
Parabilis Medicines, Inc. Filed Acc 0001231919-26-000638
Director bought 21,188,750 shares at $20.00 ($423,775,000)
- Director acquired 7,744,621 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Conversion | +6,556,740 | 6,556,740 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Conversion | +1,187,881 | 1,187,881 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Purchase | +19,728,353 | $20.00 | $394,567,060 | 26,285,093 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Purchase | +1,460,397 | $20.00 | $29,207,940 | 2,648,278 | I |
| Derivatives | |||||||
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Conversion · Series E Preferred Stock | −642,250 | 0 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Conversion · Series E Preferred Stock | −160,562 | 0 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Conversion · Series F Preferred Stock | −9,445,363 | 0 | I | ||
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-06-11 | Conversion · Series F Preferred Stock | −1,666,829 | 0 | I | ||
| Open-market purchases · 21,188,750 sh · avg $20.00 · $423,775,000 | |||||||
Loading xslF345X06/form4-06152026_100639.xml…